We evaluated the repositioning accuracy of a commercially available stereotactic whole body immobilization system (BodyFIX, Medical Intelligence, Schwabmuenchen, Germany) in 36 patients treated by hypofractionated stereotactic body radiation therapy. CT data were acquired for positional control of patient and tumor before each fraction of the treatment course. Those control CT datasets were compared with the original treatment planning CT simulation and analyzed with respect to positional misalignment of bony patient anatomy, and the respective position of the treated small lung or liver lesions. We assessed the stereotactic coordinates of distinct bony anatomical landmarks in the original CT and each control dataset. In addition, the target isocenter was recorded in the planning CT simulation dataset. An iterative optimization algorithm was implemented, utilizing a root mean square scoring function to determine the best-fit orientation of subsequent sets of anatomical landmark measurements relative to the original treatment planning CT data set. This allowed for the calculation of the x, y and z-components of translation of the patient's body and the target's center-of-mass for each control CT study, as well as rotation about the principal room axes in the respective CT data sets. In addition to absolute patient/target translation, the total magnitude vector of patient and target misalignment was calculated. A clinical assessment determined whether or not the assigned planning target volume safety margins would have provided the desired target coverage. To this end, each control CT study was co-registered with the original treatment planning study using immobilization system related fiducial markers, and the computed isodose calculation was superimposed. In 109 control setup CT scans available for comparison with their respective treatment planning CT simulation study (2-5 per patient, median 3), anatomical landmark analysis revealed a mean bony landmark translation of -0.4 ± 3.9 (mean ± SD), -0.1 ± 1.6 and 0.3 ± 3.6 mm in x, y and z-directions, respectively. Bony landmark setup deviations along one or more principal axis larger than 5 mm were observed in 32 control CT studies (29.4%). Body rotations about the x-, yand z-axis were 0.9 ± 0.7, 0.8 ± 0.7 and 1.8 ± 1.6 degrees, respectively. Assuming a rigid body relationship of target and bony anatomy, the mean computed absolute target translation was 2.9 ± 3.3, 2.3 ± 2.5 and 3.2 ± 2.7 mm in x, y and z-directions, respectively. The median and mean magnitude vector of target isocenter displacement was computed to be 4.9 mm, and 5.7 ± 3.7 mm. Clinical assessment of PTV/target volume coverage revealed 72 (66.1%), 23 (21.1%), and 14 (12.8%), of excellent (100% isodose coverage), good (>90% isodose coverage), and poor GTV/isodose alignment quality (less than 90% isodose coverage to some aspect of the GTV), respectively. Loss of target volume dose coverage was correlated with translations >5 mm along one or more axes (p<0.0001), rotations >3º about the z-axis (p=0.0007) and body mass index >30 (p<0.0001). The analyzed BodyFIX whole body immobilization system performed favorably compared with other stereotactic body immobilization systems for which peer-reviewed repositioning data exist. While the measured variability in patient and target setup provided clinically acceptable setup accuracy in the vast majority of cases, larger setup deviations were occasional observed. Such deviations constitute a potential for partial target underdosing warranting, in our opinion, a pre-delivery positional assessment procedure (e.g., pre-treatment control CT scan).
Introduction
Stereotactic body radiation therapy (SBRT) (also referred to as extracranial stereotactic radiation therapy (ESRT) or extracranial radioablation (ECRA)) is a recent conceptual development defining prescription and delivery of large single or hypofractionated radiation doses to small target volumes in lung and liver. Typically, stereotactic localization and targeting techniques, similar to those developed and established in intracranial radiosurgery, are employed. Currently, the main obstacle in enabling precise and reproducible radiation delivery outside the brain is the challenge to achieve a reliable, accurate and reproducible patient alignment and immobilization. Of particular interest is the potential variability of the targets position and motion relative to the patient's body surface.
Effective immobilization, reliable alignment and repositioning accuracy are of paramount importance to the effective and safe delivery of hypofractionated and, most critically, singledose stereotactic body radiation treatments. Several dedicated stereotactic non-invasive body immobilization systems are commercially available, and peer-reviewed data reporting the accuracy of patient repositioning are available for two of the systems (1-3). In an attempt to ensure the quality of patient immobilization and, thus, the quality of dose delivery, most currently active and planned multi-center studies researching the clinical role of stereotactic body radiation therapy stipulate the use of a body immobilization system for which peerreviewed repositioning accuracy data exist.
This report characterizes the repositioning accuracy of a new, double-vacuum assisted whole body immobilization system (BodyFIX, Medical Intelligence, Schwabmuenchen, Germany). We report patient and target translation as well as rotation within the system based on sets of anatomical landmark coordinates evaluated in the original treatment simulation CT and corresponding control CT examinations, which were conducted to evaluate the targets position immediately before radiation delivery. We also evaluate the impact of those translations and rotations on target coverage by the assigned PTV margins.
Methods and Materials
Data collection and analysis have been approved by the Institutional Review Board (IRB) of The University of Texas Health Science Center at San Antonio under IRB protocol # E-012-117.
Patient Selection for Stereotactic Body Radiation Therapy
Inclusion criteria for stereotactic body radiation therapy at the Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio and the Cancer Therapy and Research Center, San Antonio, TX are: (i) no more than three lung or liver lesions, (ii) diameter of each lesion smaller than 5 cm, (iii) patient can be positioned supine in an immobilization system for a time-frame of up to 90 minutes, and (iv) the patient is not a candidate for surgical resection (surgical or medical inoperability or patient refusal to undergo surgical resection). Of 36 patients analyzed for setup-repositioning accuracy in the present study, 26 had solitary lung or liver lesions; eight and two patients had two or three lung or liver lesions, respectively. Four patients were treated for stage 1 inoperable non-small cell lung cancer; all other patients were diagnosed with metastatic disease to the lung (n=24) and liver (n=8).
BodyFIX Whole Body Immobilization System
The BodyFIX system as analyzed for the purpose of the present study consists of a composite material base plate, variably sized sealed vacuum cushions, a clear plastic foil covering the patient's torso and lower extremities, as well as a vacuum pump ( Figure 1 ). Depending on the need for stereotactic localization and targeting, an arch-like attachment can be affixed to the base plate providing CT, MR and PET visible fiducials, as well as an integrated targeting system for stereotactic alignments in the treatment vault.
For immobilization before treatment simulation, the patient is placed supine onto a vacuum cushion, which is registered to the base plate by machined clear plastic registration bars that insert into protruding pins. The vacuum cushion is filled with small Styrofoam BBs, and has a valve attachment allowing evacuation of the enclosed air space through a vacuum pump. A clear plastic sheet is attached by a sticky rubber strip to the lower three sides of the vacuum cushion covering the patient's lower body up to the abdomen or thorax. The air between clear plastic sheet, patient, and the base vacuum cushion is evacuated while the base cushion retains its enclosed air and can thus be molded to the patient's posterior surface to provide a negative mold. Once the vacuum cushion is molded to the patient's back and sides, the enclosed air is evacuated creating a rigid, semi-permanent body cast. A typical immobilization procedure takes between 10 and 15 minutes not including the CT simulation data acquisition.
The vacuum cushions are available in various sizes. The typically used cushions in the present study range in dimension from 180 × 65 cm to 220 × 80 cm, with a constant Styrofoam BB to air ratio maintained. Cushion size was selected according to the patient's dimension, enabling immobilization of slender and relatively big patients in the same system.
Stereotactic Reference System and Imaging
The stereotactic origin for treatment planning is designated by markings on the vacuum "cast" that correspond to the CT simulation suite lasers. Laterally, BBs were placed onto the cushion at the intersection between cranio-caudal and anterior-posterior laser marking. A third BB was placed onto the patient's skin at the cranio-caudal/sagittal laser intersection. This third mark was only required for the purpose of establishing a stereotactic origin within the patient at the time of treatment simulation, as required by the used Nomos Corvus IMRT treatment planning system (Nomos Corp., Cranberry Township, PA). Additionally, markings on cranial and caudal aspects of the vacuum cushion and base plate serve to align the system according to CT simulation suite lasers and linac vault lasers for alignment of the system for positional controls and treatment.
To analyze the spatial integrity of the vacuum cushion over the treatment course, and to facilitate the assessment of patient repositioning in the system, additional lead BBs were attached to the surface of the vacuum cushion at multiple locations.
All patients were imaged during relaxed breathing using a slow helical scan with a 48 cm field of view (512 × 512 image matrix), which was reconstructed in contiguous 3 mm slices. In order to obtain sufficient anatomical detail to assess patient and target position in the treatment simulation and each control CT study, the thorax to below the liver was imaged. Extent of imaging area was individualized dependent on target volume location.
Patient Setup for Measurements of Repositioning Accuracy and Treatment
Prior to delivery of each of 2 to 5 fractions of hypofractionated stereotactic body radiation therapy, the patient was repositioned into the immobilization system on the CT couch and a CT scan with parameters identical to those of the treatment planning simulation CT scan was acquired. The immobilization system with the patient in treatment position was then transferred onto a gurney and transferred into the treatment vault. There, the BodyFIX system with patient was positioned onto the treatment couch. To control for potential patient displacement in the BodyfIX during transport from the CT simulation suite into the treatment vault, perpendicular port-films were acquired and bony landmark translations were compared with landmark translations as derived from planning CT/control CT comparison.
For treatment, the established translational deviations were corrected by translating the treatment table with body immobilization system and patient. Rotational errors were corrected when the degree of rotation caused the target volume to fall outside the computed high-dose region of the treatment plan and translational corrections would be insufficient to account the resulting setup error.
Measurement of Setup-accuracy
CT images for treatment planning and for the repositioning controls were transferred into the Corvus computerized treatment-planning system (Corvus, Nomos Corp., Cranberry Township, PA) and the planning CT dataset was registered according to the intersection of three lead BBs in the central plain of the dataset. Thus, the stereotactic origin (0, 0, 0) of the coordinate system was established. This resulted in coordinates such that for supine patients positive x-values coincided with patient left, positive y-values represented anterior and positive z-values represented cranial, respectively. For bony-landmark analysis, control CT dataset was similarly registered.
For analysis of structural changes in the immobilization system, predominantly the potential occurrence of vacuum cushion shrinkage, and assessment of target volume coverage by the prescription isodose, each control CT dataset was co-registered using a software inherent fusion module with the simulation dataset using three to four BBs attached to the vacuum cushion. The planning software supports this fiducial landmark fusion and utilizes a RMS (root-mean-square) based scoring function which allows for importance weighting of individual registration points via user defined spheres in which the required distance to agreement of the two points to be aligned is specified. For situations wherein the points align within the specified distance (here spheres of 3 mm diameter) to agreement or less, scores range between zero and one, with zero representing a perfect alignment and one representing a situation wherein the defined spheres just touch each other. For situations wherein two points cannot be made to align within the specified spheres, thus indicating a poor fusion, large penalty components to the score result in scores, which increase very rapidly above one. a As a reference for the reader, for a situation wherein we co-registered one CT data set to itself and intentionally misaligned one of three registration points on a transverse plane by one pixel (i.e., roughly 1 mm in the transverse plane and no misalignment in the cranio-caudal direction) RMS fusion scores of between 0.1 and 0.2 were observed. If one or two of three registration points were misaligned by one voxel (cranio-caudal mis-registration), RMS co-registration scores of about 0.5 were observed. Thus, since a mis-registration of two datasets by only one pixel in the transverse plane or only one voxel cranio-caudally might already result in RMS scores of up to 0.5, spatial integrity of the vacuum cushion (predominantly assumed to represent lack of shrinkage, structural damage or distortion of system) was defined when a score of 0.5 or lower was achieved.
The stereotactic coordinate of the center of mass of the target(s) was collected, as were the stereotactic coordinates of at least five discrete bony anatomical landmarks, which were to the best of our ability evenly spaced throughout the CT datasets. In order to obtain stereotactic coordinates for each of the anatomical landmarks defined, a marker-tool inherent to the software was used. The tool is a cross hair, which may be positioned over the axial, coronal and sagittal images of the image set and reports the three-dimensional stereotactic coordinates of any point defined. The coordinates for each of the anatomical structures in the reference and control datasets were transferred into a database file, along with the coordinates of each target isocenter, as derived from the reference data set for the purpose of determining body and target isocenter translation, as well as rotation about the principal room axes.
In order to avoid inter-investigator variation in identifying anatomical structures, all assessments of anatomical landmark coordinates were conducted by the same physician investigator (MF). The intra-examiner consistency of defining and re-identifying chosen anatomical landmarks has been previously assessed and the standard deviation for repeated assessments of a structure in the same dataset has been established to be smaller than 0.25 mm (4). This previously evaluated accuracy is applicable to the present evaluation since it refers solely to the ability of an investigator to identify the same pixel or voxel as containing a defined anatomical information in the same image dataset repeatedly, using the same software. The previously conducted analysis is thus independent from the type of dataset analyzed or method used to establish a coordinate system within the image or dataset. Due to the pixel dimension of approximately 0.9 × 0.9 mm and the reported standard deviation in identifying a given pixel repeatedly, the composite in-plane error of determining an accurate stereotactic coordinate is estimated as ± 1 mm. The 3 mm slice thickness we employed renders the longitudinal setup error to average ± 1.5 mm.
Data Processing
The coordinates for each set of anatomical landmarks were read into an in-house developed registration program that was specifically written to evaluate translation of a patient's body and target isocenter in a control CT data set, relative to the reference/planning data set. The optimization algorithm iteratively varied the x, y and z-translation and the rotation about the x, y and z-axes of the control data set until the root mean square variation of the control versus reference data point positions was minimized. The values reported here as the translation of the patient's body (represented by bony landmarks) and the target center-of-mass of the control data set relative to the reference data set are the values output by the program based on rigid body mechanics calculation of target movement due to the determined translations and rotations of the patient. This iterative fit technique is necessary, as opposed to a direct calculation method, because the small, but non-zero errors inherent to the process of visually identifying discrete anatomical points make it impossible to perfectly overlay the two sets of data points.
Clinical Assessment of Target Isodose Coverage
The target volume concept for all patients in the present study was delineation of the gross tumor volume without additional safety margins as the GTV. For inverse treatment planning, average transversal safety margins of 5 mm and cranio-caudal margins of 10 mm were added for a planning target volume (PTV). Individually, the need for PTV safety margins was assessed by acquiring both inhale/exhale CT simulation scans and using a simulator attached fluoroscopy unit. A dose of 36 Gy or 48 Gy in three fractions of 12 Gy or 16 Gy each, or a total dose of 36 Gy in six fractions of 6 Gy was specified to encompass at least 90% (median 95%) of the PTV. The minimum dose to the GTV was defined not to be lower than 90% of the prescription dose. The specified PTV margins (albeit narrow) were intended to be sufficient to compensate for patient repositioning inaccuracy in the immobilization system, target positional variability relative to the surface of the patient as well as secondary target movement caused by breathing, heartbeat or bowel filling.
62
Fuss et al. CT control before delivery of the first fraction, with superposition of the prescription isodose lines. The GTV is peripherally located within the 100% isodose region, no aspect of the GTV is covered by less than prescription isodose. Lower images: CT controls before the respective delivery of the first radiation fraction; superposition of the 100% (blue), 90% (red), 70% (yellow), and 50% (green) isodose lines. In both instances is the GTV fully encompassed by the 90% isodose, but some aspect of the lesion is not encompassed by the 100% isodose.
Figure 5:
Examples of poor dose coverage of lung and liver target volumes (GTV is not encompassed by at least the 90% prescription isodose line). Top images: Planning CT of a right dorsal lung metastasis (right) and a segment six liver metastasis (left). Lower images: CT controls before the respective delivery of the second (right) and third (left) radiation fraction; superposition of the 100% (blue), 90% (red), 70% (yellow), and 50% (green) isodose lines. In both instances is the GTV at least in some aspect missed by the 90% isodose. A rotation of 9.9º about the z-axis of the patients body in the control CT for the dorsal lung lesion would have caused an almost complete miss of the target volume and a significant dose exposure of the spinal cord, if correctional measures would not have been applied. All control datasets were assessed for positional correlation of the GTV's position with the calculated isodose distribution by virtual dose superposition onto the co-registered control dataset. All datasets were reviewed on a full slice-byslice basis. Full GTV coverage by the 100% isodose was scored excellent (Figures 2 and 3) , coverage by at least the 90% isodose was scored good (Figure 4) , and any loss of coverage below 90% was scored poor ( Figure 5 ).
In addition to this clinically relevant assessment, we calculated correlation of the dose coverage score with the magnitude of computed body and target translation, as well as with the computed rotational component, to assess if body landmark assessment would sufficiently predict target volume dose coverage by the chosen PTV margins. Statistical analysis of this correlation was conducted using chi-squared and Fisher's exact test, where appropriate.
Patient Weight as a Potential Factor Impacting on Repositioning Accuracy
The weight (in kg) and the body-mass-index (BMI=weight (kg)/length (m) 2 ) of the patients at the time of molding of the immobilization device was recorded (mean BMI 26.2 ± 4.5, median 26.2, range 18.1 to 38.5) and correlated with body and target translations and rotations.
Local Control as a Surrogate for the Achieved Repositioning Accuracy
Since the numeric representation of the repositioning accuracy of any immobilization system has a benchmark clinical criterion as the ultimate measure of its capabilities, assuming a sufficient radiation dose for local tumor control, we assessed the 3, 6, and 12 months local control rates in the analyzed patient population. Local control was determined in followup imaging CT and PET studies. Actuarial local control rates were estimated using Kaplan-Meier curves, where local failure at a given time point was entered as an event and the individually most recent recorded time of confirmed local control in the absence of local failure was entered as a censor variable.
Results

Spatial Integrity of the BodyFIX System
Of 109 total control CT studies, 64 (58.7%) were co-registered to their respective simulation CT study achieving a RMS score <0.1, representative of a near perfect co-registration of the registration points in space. The remaining 45 (41.3%) datasets were co-registered achieving a RMS score lower 0.39, indicating a mis-registration of original and control CT data set by no more than one pixel/voxel between the respective registration points. Thus, according to our requirement that only RMS scores lower than 0.5 would represent an undisturbed spatial relation of the attached BBs, all controls indicated that the spatial integrity of the vacuum cushion was maintained. This finding was supported by the clinical observation that none of the used vacuum cushions lost an appreciable amount of vacuum over time. Consistent with our clinical observations, there was no correlation of time or number of already performed treatments with quality of marker spatial correlation.
Analysis of CT Setup Control -Body Repositioning Accuracy
The mean deviation of anatomical landmark coordinates in the control data sets compared with the treatment simulation CT dataset was -0.4 ± 3.9 mm (mean±SD), -0.1 ± 1.6 mm, and 0.3 ± 3.6 mm along the x-, y-, and z-axis, respectively. Absolute average landmark shifts along the respective axes was 2.9 ± 3.4 mm, 1.5 ± 1.0 mm, and 2.8 ± 2.2 mm. In a total of 32 control CTs (29.4%), setup deviations larger than 5 mm were observed along one (n=31) or two (n=1, x and z axis) principal axes. The median and mean 3D magnitude vector of body translation in the BodyFIX system was 4.0 mm and 4.8 ± 3.4 mm, respectively. Mean patient body rotations about the x-, y-and z-axis in the immobilization system were 0.9 ± 0.7, 0.8 ± 0.7 and 1.8 ± 1.6 degrees, respectively. Rotations larger than 1º, 2º, and 3º about the x-axis were observed 37, 10, and 2 times, and about the y-axis in 31, 10 and 0 instances, respectively. About the z-axis such rotational setup errors were observed in 70, 33, and 16 control CT studies with 4 instances in which rotations larger than 5º were observed. Maximum observed rotations about the x, y, and z-axis were 3.1, 2.9, and 9.9 degree, respectively.
Analysis of CT Setup Control -Target Repositioning Accuracy
Average nominal and absolute respective target center of mass translations in the x, y and z-directions were -0.2 ± 4.4, -0.2 ± 3.5, and 0.4 ± 4.2 mm, as well as 2.9 ± 3.3, 2.3 ± 2.5, and 3.2 ± 2.7 mm, respectively. The median and mean 3D magnitude of target translation was 4.9 mm and 5.7 ± 3.7 mm (mean ± SD), respectively.
Target Volume Coverage by the PTV
Of 109 control CT assessments, before correctional measures on the treatment table were applied, the GTV was completely covered by the 100% isodose line in 66.1% (excellent score), covered at least by the 90% isodose line in 21.1% (good score), and missed in some aspect by the 90% isodose line in 12.8% (n=14, poor score), respectively. The PTV failed to provide GTV coverage along the cranio-caudal axis in 9/14 such instances (3 lung lesions, 6 liver lesions) and in the transversal plane in the remaining instances (5/14, all lung lesions). In six patients, one of the three daily setups showed a PTV miss; in one patient a PTV miss was recorded twice and in two patients a PTV miss was recorded three times.
Loss of target volume coverage correlated with magnitude of bony landmark translation larger than 5 mm along any principal axis (p<0.0001) and rotation about the z-axis larger than 3 degrees (p=0.0007). Rotations about the x-and yaxes were not correlated with loss of target volume coverage by the computed 90% isodose.
BMI was significantly correlated with loss of target volume coverage for obese patients (BMI >30, p<0.0001). There was no statistical difference in the probability of target volume dose coverage between normal (BMI <25) and heavy patients (BMI between 25 and 30) (p=0.2). The probability of loss of target volume dose coverage was 5% at BMI 25.6, 25% at BMI 30 and increased to 50% at a BMI of 32.8. Observation of bony landmark translation larger 5 mm and rotation larger than 3º about the z-axis were significantly correlated with BMI >30 (p=0.024 and p=0.003), while the respective correlation between normal and heavy patients was not found to be significantly different (p=0.8 and p=0.12).
Local Tumor Control as a Surrogate Marker of Setup Accuracy and Correctional Measures
In 46/48 lesions assessed in the present study (95.8%), local control was achieved at the time of the last available imaging follow-up (mean imaging follow-up 5.9 months, range 1.0 to 17 months). Two lesions failed locally at 5 and 6 months of imaging follow-up, one of them could be success-fully salvaged by repeated stereotactic body radiation therapy. Estimated three, six, and 12-months local control rates as derived from Kaplan-Meier local control analysis were 100%, 94.4%, and 88.5%, respectively ( Figure 6 ). At 6 and 12 months, the confidence intervals ranged from 83% to 100% and 74% to 100%, respectively. Local tumor control was not correlated with initial patient and target setup accuracy, suggesting that the corrective measures that were performed on the linac treatment table were sufficient to compensate the recognized setup errors.
Discussion
The primary purpose of any immobilization system is the precise alignment of the defined target relative to the isocenter of the radiation treatment machine by means of repositioning the patient's body accurately and reproducibly on the treatment table. Accurate and reproducible setup of small target volumes in lung and liver is of the utmost importance in the delivery of large single or hypofractionated radiation doses as typically applied in stereotactic body radiation therapy, or radioablation. The very narrow PTV safety margins that are typically assigned for such treatments (5 mm axial and 10 mm cranio-caudal in the present study) are intended to account for patient setup inaccuracies, variability of target position relative to the patient's body surface and target motion under treatment. The present study analyzed the capability of the BodyFIX double-vacuum whole-body immobilization system to provide for the required patient and target setup accuracy as required under such treatment paradigms.
The system analyzed in the present study is one of various body-immobilization systems specifically designed to provide such patient and target setup accuracy for extracranial stereotactic radiation therapy. Performance data published by Lax et al., Wulf et al., Lohr et al., and Herfarth et al. currently provide the most comprehensive characterization of patient setup accuracy provided by the Stereotactic Bodyframe (Elekta Corp., Norcross, GA), and the University of Heidelberg specific circumferential whole body mask system, which represents a modification of the commercially available associated stereotactic body frame (Leibinger, Freiburg, Germany) for which peer-reviewed data also exists (1-3, 5). All publications provide data on patient setup accuracy as derived from bony landmark analysis. Differences in the method of bony landmark assessment refer predominantly to the assessment of the stereotactic coordinates of the anterior and lateral surfaces of vertebral body and posterior processes (2, 3, 5) in the central (target isocenter) plane, whereas the present analysis refers to characteristic anatomical landmarks in or adjacent to vertebral bodies (small compacta islands or small lacunas, distinct calcifications and implanted materials such as bone screws and wires). We do perceive an advantage of collecting the stereotactic coordi- nates of such distinct anatomical features with respect to the collection of x, y and z-coordinates. Bone surfaces may provide a reliable assessment of the x-and y-coordinates but may fail to provide a sufficient knowledge of setup errors along the cranio-caudal axis. Consistent with lack of an assessment of a z-coordinate, Lohr and Herfarth state that deviations along the cranio-caudal axis were < 3 mm and < 5 mm, respectively (thus within specified CT slice thickness) (2, 5).
Wulf et al. also collected their bony anatomy data according to surface bony reference structures using a 'mark and measure' tool to derive setup deviations between the simulation and a solitary CT control data set (3). In their analysis, the respective z-coordinate of the target slice, representing the isocenter slice of the simulation CT best in the control CT data set, was derived from the axial distance of wires embedded into the sideboard of the SBF immobilization system. Despite the institutional differences in establishing the data to derive the accuracy of the analyzed body immobilization systems, we attempted to compare the data presented in the present analysis to core data derived from these publications.
Comparable to the Wuerzburg data which reported a standard deviation of the SBF system for alignment errors along the principal room axes of 3.9, 2.2 and 3.5 mm in x (latero-lateral), y (antero-posterior) and z (cranio-caudal) direction (3), we found standard deviations of 3.9, 1.6, and 3.6 mm, respectively. Similar data reported by the Heidelberg group for a vacuum cushion system and a circumferential body mask system indicate slightly smaller standard deviation along the x-(1.6 and 1.4 mm for thoracic and lumbar spine lesions, respectively) and y axis (1.4 and 1.2 mm) (5). Setup variability, for therapy of liver lesions showed standard deviations of 1.2 and 3.8 mm in x-and y-axis, respectively (2). As pointed out earlier, according to the methodology of collecting and reporting data by the Heidelberg group, standard deviation for setup errors along the z-axis were not reported. It should be noted that the repositioning accuracy data for the vacuum cushion assisted treatments of small liver lesions was reported as the residual system setup error following setup corrections of the patients within the system in 16/26 assessed patients (61.5%; median 3 correctional attempts in those patients). Thus, these data compare in only a limited way with the data reported here and those reported by Wulf et al. Indirectly, however, Herfarth et al. report that the patients that were corrected within the immobilization system expressed initial setup errors of larger than 5 mm along one or more principal axes. In the present analysis, the median initial or raw absolute setup error was 2.6, 1.9, and 2.8 mm along the x, y and z-axis, respectively. Thirty-two of 109 patient repositioning controls (29.4%) were found to have more than 5 mm setup error along one (n=31) or more principal axes (n=1, x and z axis) before corrective measures on the linac treatment couch were applied. Thus, more than 70% of assessed setups in the present study would not have under-gone any correction according to the reported Heidelberg guideline. The value of correcting the patient position within the immobilization system if bony landmark setup errors larger than 5 mm are observed, is supported by the statistically significant correlation of loss of target volume coverage by the prescription isodose in the present study.
Rotational setup errors in immobilization systems dedicated to stereotactic body radiation therapy have not been quantified before, although their influence on translational setup errors along the principal room axes has been acknowledged (2, 6). Average rotational setup errors were found to be largest about the z-axes, which might be explained by the lack of freedom to rotate about the x and y-axis. Rather small rotations (<2º) were commonly observed, and rotational errors larger than 3º and 5º about the z-axis were still observed in 14.7%, and 3.7% of patients with a maximum observed rotational error of 9.9º. Rotations about the z-axis larger than 3º were strongly correlated with the probability of loss of target volume coverage by the planned dose distribution. These findings are an indication that even sophisticated body immobilization devices may fail to provide the desired positional accuracy of patient's body and the target volume in selected cases. It is noteworthy that the measured rotation was not apparent from the patient skin marks that we use as guidance when repositioning the patients in the BodyFIX system. Not surprisingly, clinically relevant rotational and translational errors were predominantly observed in obese patients, in which the body mass index exceeded 30. The only other publication stating a body mass index of patients treated, reported a median BMI of 25.3 and a range of up to 30, but no correlation of setup accuracy with BMI was performed (2). The patient population in the present study represents the typical dilemma of patients presenting for radiation therapy in our department. San Antonio has gained a somewhat dubious reputation for being the "largest city" in United States and, accordingly, a significant percentage of patients referred to our center are overweight. Although we document with the present data that repositioning accuracy for big patients may be compromised, with a resulting increase in the probability for loss of target volume dose coverage if corrective measures are omitted, the present study is also supportive of the ability of the analyzed immobilization system to accommodate such patients. Within the limited experience gained using the BodyFIX system we did not experience patient size as a prohibitive factor to patient immobilization and the delivery of stereotactic body radiation therapy.
Target volume coverage by the assigned PTV using 5 mm transversally and 10 mm cranio-caudally provided sufficient pre-correction target volume coverage (defined as coverage by at least the 90% isodose) in 87.1% of setups. At the isocenter level, Wulf et al. report similar target coverage in 13/15 cases in which non-fixed target volumes were treated (3). Data provided by Lax et al., referring to 28 alignments, suggest sufficient target coverage by identical PTV safety margins in 93% transversally and 88% cranio-caudally (1). Analyzing the present data according to this method of assessment, the chosen patient setup and PTV safety margin in the present study provided sufficient target volume dose coverage in 95.5% and 91.8% of alignments in the transversal plane and cranio-caudally, respectively. Since this assessment was based on imaging acquired under relaxed breathing, tumor dislocation secondary to inhalation and exhalation was inherently accounted for in the present analysis as it was in the referred studies with which the present data are compared. We would like to make clear, that all patients underwent perpendicular port-film setup verification on the linac treatment table and setup corrections congruent with the displacement findings in the analyzed CT control studies were performed. Even if the PTV margin would have provided sufficient GTV coverage but the target was located peripherally in the 100% isodose distribution it was attempted to center the target more optimally relative to the dose distribution. We thus assume, that 100% of setups were sufficiently corrected by the time the radiation treatment was delivered. This assumption is supported by the estimated actuarial local control rate of 94.4%, and 88.5% at 6 and 12 months (lower confidence intervals of 83% and 74%, respectively) of follow-up in the analyzed population.
In summary, the present data regarding the patient and target volume setup reproducibility in the BodyFIX double-vacuum whole body immobilization system are strongly supportive of its capability to provide the required accuracy of patient setup for stereotactic body radiation therapy. Comparable to other dedicated stereotactic body immobilization systems, a subset of patient setups, predominantly obese patients, will show setup variability with respect to translations along one or more principal axes of larger 5 mm and/or rotations about the z-axis larger than 3º, with the associated risk of target volume underdosing. While such body setup errors may be in part correctable by acquiring port-films in treatment position on the linac couch (2, 3), the relative motion and position of the target volume relative to the bony skeleton may not always be sufficiently appreciated. Thus, a more sophisticated positional assessment of the target's relation with the planned isodose distribution is, in our opinion, warranted. While the approach used in the present study requires significant resources, both technical (simulation CT times) and personnel on each of the treatment days, such positional controls may be facilitated in the future by now available linac-attached cone-beam CT systems, in-room CT scanners or use of a Tomotherapy unit with implemented mega-voltage CT imaging capabilities.
